Chris Finan
Impact in
- Genetics top 5%
- Genetic Associations and Epidemiology
- Molecular Biology top 10%
- Bioinformatics and Genomic Networks
- Microbial Metabolic Engineering and Bioproduction
Papers in
-
- Bioinformatics and Genomic Networks 6
- Microbial Metabolic Engineering and Bioproduction 5
- Genetics 20
- Genetic Associations and Epidemiology 18
- Genomics and Rare Diseases 4
- Co-authors
- Amand F. Schmidt (24 shared papers)Aroon D. Hingorani (21 shared papers)Juan P. Casas (4 shared papers)Anna Gaulton (2 shared papers)John P. Overington (2 shared papers)Felix Krüger (2 shared papers)Melanie J. Newport (8 shared papers)Jorgen Engmann (2 shared papers)
- Journals
- Nature Communications (4 papers)PLoS ONE (4 papers)Journal of Industrial Microbiology & Biotechnology (3 papers)Scientific Reports (2 papers)EBioMedicine (2 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Chris Finan
43 papers receiving 2.1k citations
Chris Finan's Hit Papers
Peers
Comparison fields: 5 of 184
- Genetics 521
- Molecular Biology 709
- Physiology 233
- Computational Theory and Mathematics 138
- Infectious Diseases 143
Countries citing papers authored by Chris Finan
This map shows the geographic impact of Chris Finan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Finan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Finan more than expected).
Fields of papers citing papers by Chris Finan
This network shows the impact of papers produced by Chris Finan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Finan. The network helps show where Chris Finan may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Finan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The druggable genome and support for target identification and validation in drug development Hit paper breakdown → | 2017 | 494 |
| 2 | Linear regression and the normality assumption Hit paper breakdown → | 2017 | 399 |
| 3 | Genetic drug target validation using Mendelian randomisation Hit paper breakdown → | 2020 | 267 |
| 4 | 2019 | 129 | |
| 5 | 2012 | 112 | |
| 6 | 2019 | 93 | |
| 7 | 2019 | 79 | |
| 8 | 2020 | 69 | |
| 9 | 2012 | 46 | |
| 10 | 2010 | 46 | |
| 11 | 2011 | 45 | |
| 12 | 2023 | 38 | |
| 13 | 2014 | 34 | |
| 14 | 2015 | 32 | |
| 15 | 2008 | 29 | |
| 16 | 2020 | 23 | |
| 17 | 2021 | 20 | |
| 18 | 2024 | 20 | |
| 19 | 2021 | 19 | |
| 20 | 2022 | 17 |
About Chris Finan
Chris Finan is a scholar working on Molecular Biology, Genetics, Surgery, Cardiology and Cardiovascular Medicine and Immunology, having authored 48 papers that have together received 2.1k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (18 papers), Lipoproteins and Cardiovascular Health (8 papers), Bioinformatics and Genomic Networks (6 papers), Microbial Metabolic Engineering and Bioproduction (5 papers), Computational Drug Discovery Methods (4 papers), Biofuel production and bioconversion (4 papers), Genomics and Rare Diseases (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). The work is most often cited by research in Genetics (521 citations), Molecular Biology (709 citations), Physiology (233 citations), Computational Theory and Mathematics (138 citations) and Infectious Diseases (143 citations). Chris Finan has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Amand F. Schmidt, Aroon D. Hingorani, Juan P. Casas, Anna Gaulton, John P. Overington, Felix Krüger, Melanie J. Newport, Jorgen Engmann, Rita Santos and Anneli Karlsson. Their work appears in journals such as Nature Communications, PLoS ONE, Journal of Industrial Microbiology & Biotechnology, Scientific Reports and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.